Search Results

Displaying Results 476-500 of 591 "'CR'"

Aug 14, 2025, 16:05 ET Tyra Biosciences Reports Second Quarter 2025 Financial Results and Highlights

with dabogratinib at 50 mg once-daily (QD) (Cohort 1) or treatment with dabogratinib at 60 mg QD (Cohort 2). The primary endpoint is complete response (CR) rate at three months. Secondary endpoints include time to recurrence, median duration of response, recurrence free survival, progression free survival,

More news about: Tyra Biosciences


Aug 14, 2025, 09:00 ET DuPont Water Solutions Wins BIG Sustainability Award for Advancements in Industrial Wastewater Reuse

Over the past year, DuPont has introduced several new and upgraded FilmTec™ Fortilife™ membranes to the market — including product grades such as CR100, XC70, XC120HR, and XC160 — pushing the boundaries of brine concentration and energy efficiency. These innovations not only support global momentum

More news about: DuPont


Aug 14, 2025, 05:25 ET UGRO CAPITAL ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025

INR 12,081 Cr, up 31% YoYTotal Income stood at INR 421.8 Cr in Q1'FY26, up 40% YoYNet Total Income at INR 216.5 Cr, up 31% YoYGNPA/NNPA at 2.5%/1.7% on total AUMEmbedded Finance Growth: Reached INR 1,011 Cr AUM with INR 582 Cr disbursed in

More news about: UGRO Capital Limited


Aug 14, 2025, 00:55 ET Q1 FY26 - Delivers 63% YoY PAT Growth; Strengthens Balance Sheet with ₹900 Cr QIP

multimedia:https://www.prnewswire.com/in/news-releases/q1-fy26---delivers-63-yoy-pat-growth-strengthens-balance-sheet-with-900-cr-qip-302529809.html

More news about: Marathon NextGen Realty Ltd


Aug 12, 2025, 16:05 ET INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

initial 12-month Phase 1/2 trial (Year 1) to 86% at the end of the second 12-month period (Year 2)Patients experiencing a Complete Response (CR - 0 surgeries per year) increased from 28% for Year 1 to 50% for Year 2Mean number of surgeries was reduced from 4.1 in the pre-treatment period

More news about: INOVIO Pharmaceuticals, Inc.


Aug 12, 2025, 09:00 ET VELOCITY STABILIZES RESTOMOD INDUSTRY WITH THE ACQUISITION OF CLASSIC RECREATIONS

industry, the world's largest bespoke restomod company acquires the assets of Classic Recreations, expanding its product offerings and supporting existing CR customers. PENSACOLA, Fla., Aug.

More news about: Velocity Modern Classics


Aug 12, 2025, 09:00 ET Mercury Insurance Unveils This Year's Most Affordable New Trucks and SUVs to Insure

FeHonda PilotChevrolet BlazerKia SportageHonda PassportFord EscapeKia SoulHonda HR-VHonda CR-VKia Sorento"Choosing a vehicle with utility doesn't have to break the bank, as any of these vehicles

More news about: Mercury General Corporation


Aug 12, 2025, 07:30 ET ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated overall response rate (ORR) of 93.3% and a complete response (CR) rate of 86.7% in LOTIS-7 across 30 efficacy evaluable patients Expansion to 100 r/r DLBCL

More news about: ADC Therapeutics SA


Aug 12, 2025, 05:50 ET Steele Honda Adds the 2026 Honda CR-V to Its Inventory in St. John's, Newfoundland

Aug. 12, 2025 /PRNewswire/ -- Drivers in St. John's can now test drive the 2026 Honda CR-V at the Steele Honda dealership.

More news about: Steele Honda


Aug 12, 2025, 04:19 ET Caliway Met Dual Milestones with MSCI Global Standard Index Inclusion, and Health Canada has Approved the Phase 3 SUPREME-01 Study

accordance with U.S. FDA guidance and relevant regulations, including the FDA's guideline on Patient-Focused Drug Development. The Clinician Reported-AFRS (CR-AFRS) and the Patient Reported-AFRS (PR-AFRS) are used to assess treatment response based on the physician's evaluation and the participant's self-assessment,

More news about: Caliway Biopharmaceuticals


Aug 11, 2025, 08:05 ET Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

end of the second 12-month period (Year 2) compared to 72% observed at the end of the initial 12-month Phase 1/2 trial (Year 1); the Complete Response (CR) rate improved to 50% for Year 2 from 28% for Year 1Mean number of surgeries patients needed to control their RRP continued to drop from

More news about: INOVIO Pharmaceuticals, Inc.


Aug 07, 2025, 09:03 ET Crunch Fitness Franchisee CR Fitness Holdings Donates Gym Equipment to New Ronald McDonald House at St. Joseph's Children's Hospital

RMHCTB helps families focus on what matters most, caring for their child. For more information, visit rmhctampabay.org. About CR Fitness Holdings, LLCCR Fitness Holdings, LLC is the leading franchisee of Crunch Fitness. Led by industry veterans Vince Julien,

More news about: CR Fitness Holdings, LLC.


Aug 07, 2025, 01:25 ET A23 launches the 3rd season of Rummy Indian Open with a ₹25 Crore prize pool and a high-stakes finale in Goa

starts August 1, 2025 and will conclude on September 30, 2025. With a prize pool of over ₹25 Cr, RIO is set to unite over 3.5 lakh rummy enthusiasts, competing with each other on the A23 Rummy app.

More news about: Head Digital Works


Aug 06, 2025, 14:30 ET NIIT Learning Systems Limited (NIIT MTS) Announces Q1 FY'26 (April-June 2025) Results

June 2025 quarter, the company recorded a consolidated Net Revenue of Rs. 451.4 Cr, up 5% QoQ and 11% YoY. EBITDA was Rs. 95.1 Cr while EBITDA Margin stood at 21%. Profit After Tax was Rs. 49.3 Cr. EPS for the quarter was Rs. 3.62. The results were taken on record at the meeting of

More news about: NIIT (USA), INC.


Aug 05, 2025, 08:39 ET Tarrytown Honda Earns Honda President's Award

with the HR-V, CR-V, Passport, Prologue and Pilot sport utility vehicles, the Ridgeline pickup and the Odyssey minivan. The Honda electrified vehicle lineup, representing more than a quarter of total sales in 2024, includes the all-electric Prologue SUV, hybrid-electric Accord, CR-V, and Civic, and Fuel-Cell-electric

More news about: Tarrytown Honda


Jul 31, 2025, 16:01 ET Coveo Reports First Quarter Fiscal 2026 Financial Results

https://emportal.ink/44cR5CQUse the link above to join the conference call without operator assistance. If you prefer to have operator assistance, please

More news about: Coveo Solutions Inc.


Jul 31, 2025, 11:31 ET Aarti Industries Demonstrates Resilience in Challenging Q1; Strategic Expansions and Diversified Portfolio Set Stage for Recovery

long-term growth agenda. On a consolidated basis, income from operations stood at ₹ 1,867 Cr, compared to ₹ 2,214 Cr in Q4 FY25. EBITDA stood at ₹ 215 Cr, while Profit After Tax (PAT) stood at ₹ 43 Cr. While financial performance was impacted in the short term, the underlying health of the business

More news about: Aarti Industries


Jul 31, 2025, 08:30 ET Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficacy in Combination with ARPI Therapy at the 4th Annual Targeted Radiopharmaceuticals Summit

relapsed and refractory acute myeloid leukemia (r/r AML) patients in combination with the chemotherapy CLAG-M including high rates of Complete Remissions (CR) and measurable residual disease (MRD) negativity leading to improved survival outcomes and is being advanced to a pivotal Phase 2/3 trial. In addition,

More news about: Actinium Pharmaceuticals, Inc.


Jul 30, 2025, 10:03 ET DigiKey Expands Inventory with Over 32,000 Stocking NPIs in Q2 2025

High Temperature CR2032 batteries are designed to withstand temperatures up to 125 degrees Celsius.The new u-blox

More news about: DigiKey


Jul 30, 2025, 09:00 ET CRŪ Winery Announces 2nd Annual Chowder Cook-Off Contest

download multimedia:https://www.prnewswire.com/news-releases/cr-winery-announces-2nd-annual-chowder-cook-off-contest-302516475.html SOURCE

More news about: CRU Winery


Jul 30, 2025, 02:14 ET Star Health Insurance Reports Strong Performance Q1FY26 PAT Grows 44% to INR 438 Cr (IFRS), Premium Grows 13%

and 14,700+ employees. In FY25, Star Health's gross written premium stood at Rs.17, 553 Cr with its net worth at Rs.8,668 Cr. For more information visit www.starhealth.in

More news about: Star Health and Allied Insurance


Jul 29, 2025, 17:39 ET Majestic Garden Show Village Debuts Globally

of Shanghai NANFANG Group; Wang Xinyi, General Manager of CR Land East China Regional Company; Hong Li, Deputy Party Secretary and General Manager of Shanghai NANFANG Group; and Lou Shanjie, General Manager of CR Land Shanghai Company. Together, they witnessed this milestone

More news about: Majestic Garden


Jul 28, 2025, 20:59 ET 康霈CBL-514獲美國FDA核准啟動SUPREME-01 成全球首項「減少腹部皮下脂肪」樞紐三期臨床試驗

Patient-Reported Outcome Measures 相關法規要求所開發並完成確效的腹部皮下脂肪堆積評量表(Abdominal Fat Rating Scale),並已通過FDA書面審查。該量表分為1到5級,等級越高代表腹部皮下脂肪堆積越嚴重,不同等級在臨床上具有顯著差異。 - CR-AFRS ( Clinician Reported Abdominal Fat Rating Scale) 代表由試驗醫師評估受試者之腹部皮下脂肪堆積等級; - PR-AFRS ( Patient Reported Abdominal Fat Rating Scale) 則代表由受試者自評之腹部皮下脂肪堆積等級。

More news about: 康霈生技


Jul 28, 2025, 10:01 ET Hemostats Market is expected to generate a revenue of USD 4.25 Billion by 2031, Globally, at 5.81% CAGR: Verified Market Research®

"Global Hemostats Market" study report will provide a valuable insight with an emphasis on the global market.  The major players in the market are CR Bard, Inc., Braun Melsungen AG, Baxter International Inc., Integra LifeSciences, Marine Polymer Technologies Inc., Teleflex, Ethicon Inc., Pfizer Inc.,

More news about: Verified Market Research


Jul 28, 2025, 08:00 ET Servier Announces Positive Data from Long-Term Follow-Up Analysis of the Phase 3 AGILE Trial of TIBSOVO® (ivosidenib) in IDH1-mutated Acute Myeloid Leukemia

failure to achieve complete remission (CR) by Week 24. Key secondary endpoints included CR rate, defined as the proportion of participants who achieve a CR; overall survival (OS), defined as the time from date of randomization to the date of death due to any cause; CR and complete remission with partial

More news about: Servier Pharmaceuticals


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.